0.021 HKD
26.66 M HKD
1.18 B HKD
About SHENZHEN NEPTUNUS INTERLONG BIO-TEC
Sector
Headquarters
Hong Kong
Founded
1994
Website
ISIN
CNE100000775
FIGI
BBG000BK8TN5
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines, and healthcare food products. It operates through the Manufacturing and Selling of Medicines and Sales and Distribution of Medicines and Healthcare Products segments. The company was founded on November 15, 1994 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8329 is 0.160 HKD — it has increased by 12.68% in the past 24 hours. Watch SHENZHEN NEPTUNUS INTERLONG BIO-TEC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHENZHEN NEPTUNUS INTERLONG BIO-TEC stocks are traded under the ticker 8329.
8329 stock has risen by 17.65% compared to the previous week, the month change is a 17.65% rise, over the last year SHENZHEN NEPTUNUS INTERLONG BIO-TEC has showed a 13.48% increase.
8329 reached its all-time high on May 4, 2007 with the price of 3.850 HKD, and its all-time low was 0.116 HKD and was reached on Sep 28, 2022. View more price dynamics on 8329 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
8329 stock is 19.44% volatile and has beta coefficient of 0.26. Track SHENZHEN NEPTUNUS INTERLONG BIO-TEC stock price on the chart and check out the list of the most volatile stocks — is SHENZHEN NEPTUNUS INTERLONG BIO-TEC there?
Today SHENZHEN NEPTUNUS INTERLONG BIO-TEC has the market capitalization of 268.48 M, it has increased by 8.40% over the last week.
Yes, you can track SHENZHEN NEPTUNUS INTERLONG BIO-TEC financials in yearly and quarterly reports right on TradingView.
8329 net income for the last half-year is 41.08 M HKD, while the previous report showed −6.22 M HKD of net income which accounts for 760.80% change. Track more SHENZHEN NEPTUNUS INTERLONG BIO-TEC financial stats to get the full picture.
No, 8329 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 1.44 K employees. See our rating of the largest employees — is SHENZHEN NEPTUNUS INTERLONG BIO-TEC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHENZHEN NEPTUNUS INTERLONG BIO-TEC EBITDA is 97.41 M HKD, and current EBITDA margin is 7.11%. See more stats in SHENZHEN NEPTUNUS INTERLONG BIO-TEC financial statements.
Like other stocks, 8329 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHENZHEN NEPTUNUS INTERLONG BIO-TEC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHENZHEN NEPTUNUS INTERLONG BIO-TEC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHENZHEN NEPTUNUS INTERLONG BIO-TEC stock shows the neutral signal. See more of SHENZHEN NEPTUNUS INTERLONG BIO-TEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.